IL157703A0 - Methods for delivering nucleic acid molecules into cells and assessment thereof - Google Patents

Methods for delivering nucleic acid molecules into cells and assessment thereof

Info

Publication number
IL157703A0
IL157703A0 IL15770303A IL15770303A IL157703A0 IL 157703 A0 IL157703 A0 IL 157703A0 IL 15770303 A IL15770303 A IL 15770303A IL 15770303 A IL15770303 A IL 15770303A IL 157703 A0 IL157703 A0 IL 157703A0
Authority
IL
Israel
Prior art keywords
assessment
cells
methods
nucleic acid
acid molecules
Prior art date
Application number
IL15770303A
Original Assignee
Chromos Molecular Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/815,979 external-priority patent/US7294511B2/en
Priority claimed from US09/815,981 external-priority patent/US6936469B2/en
Priority claimed from US10/086,745 external-priority patent/US20030186390A1/en
Application filed by Chromos Molecular Systems Inc filed Critical Chromos Molecular Systems Inc
Publication of IL157703A0 publication Critical patent/IL157703A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0047—Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
IL15770303A 2001-03-22 2003-02-22 Methods for delivering nucleic acid molecules into cells and assessment thereof IL157703A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/815,979 US7294511B2 (en) 2001-03-22 2001-03-22 Methods for delivering nucleic acid molecules into cells and assessment thereof
US09/815,981 US6936469B2 (en) 2001-03-22 2001-03-22 Methods for delivering nucleic acid molecules into cells and assessment thereof
US10/086,745 US20030186390A1 (en) 2001-03-22 2002-02-28 Methods for delivering nucleic acid molecules into cells and assessment thereof
PCT/US2002/009262 WO2002076508A1 (en) 2001-03-22 2002-03-22 Methods for delivering nucleic acid molecules into cells and assessment thereof

Publications (1)

Publication Number Publication Date
IL157703A0 true IL157703A0 (en) 2004-03-28

Family

ID=27375461

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15770303A IL157703A0 (en) 2001-03-22 2003-02-22 Methods for delivering nucleic acid molecules into cells and assessment thereof

Country Status (6)

Country Link
EP (1) EP1383541A4 (en)
JP (1) JP2004532205A (en)
CA (1) CA2441535C (en)
IL (1) IL157703A0 (en)
NZ (1) NZ527972A (en)
WO (1) WO2002076508A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294511B2 (en) 2001-03-22 2007-11-13 Chromos Molecular Systems, Inc. Methods for delivering nucleic acid molecules into cells and assessment thereof
CA2441937A1 (en) 2001-05-30 2002-12-05 Chromos Molecular Systems, Inc. Chromosome-based platforms
JP4676679B2 (en) * 2003-04-02 2011-04-27 帝人株式会社 Artificial cartilage
NZ554824A (en) 2004-10-22 2010-10-29 Revivicor Inc Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
JP5115686B2 (en) * 2006-04-17 2013-01-09 学校法人慶應義塾 Drug introduction device to cells
EP2348827B1 (en) 2008-10-27 2015-07-01 Revivicor, Inc. Immunocompromised ungulates
EP3544497A4 (en) * 2016-11-22 2020-08-05 Cedars-Sinai Medical Center A novel transfection and drug delivery device
CN117357480B (en) * 2023-12-08 2024-03-29 北京中科利华医药研究院有限公司 Composition for needleless percutaneous injection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ253943A (en) * 1992-06-18 1997-01-29 Genpharm Int Transfering polynucleotides into eukaryotic cells using co-lipofection complexes of a cationic lipid and the polynucleotide
US5830430A (en) * 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
NL1000884C2 (en) * 1995-07-25 1997-01-28 Univ Groningen Transport vehicles for macromolecules.
US6184037B1 (en) * 1996-05-17 2001-02-06 Genemedicine, Inc. Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
US6074667A (en) * 1996-11-20 2000-06-13 Kinnunen; Paavo Liposomal transfection method
WO1999025385A1 (en) * 1997-11-17 1999-05-27 Imarx Pharmaceutical Corp. A method of increasing nucleic acid synthesis with ultrasound
CA2353559A1 (en) * 1998-12-04 2000-06-15 Genetronics, Inc. Facs assisted methods for introducing individual chromosomes into cells

Also Published As

Publication number Publication date
EP1383541A1 (en) 2004-01-28
CA2441535A1 (en) 2002-10-03
WO2002076508B1 (en) 2002-12-12
EP1383541A4 (en) 2009-11-04
CA2441535C (en) 2008-08-26
WO2002076508A1 (en) 2002-10-03
NZ527972A (en) 2006-04-28
JP2004532205A (en) 2004-10-21

Similar Documents

Publication Publication Date Title
AU2003221584A8 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
GB0402773D0 (en) Methods and means for nucleic acid sequencing
AU2003206095A1 (en) Methods and means for amplifying nucleic acid
AU2001273453A1 (en) Nucleic acid hairpin probes and uses thereof
IL166612A0 (en) Circular nucleic acid vectors and methods for making and using the same
AU2002350485A1 (en) Device for sequencing nucleic acid molecules
AU2003212954A8 (en) Skin cell biomarkers and methods for identifying biomarkers using nucleic acid microarrays
EP1664298A4 (en) Modified gene-silencing nucleic acid molecules and uses thereof
GB9929381D0 (en) A method of assessing the amount of nucleic acid in a sample
EP1339875A4 (en) Compositions and methods for rapidly generating recombinant nucleic acid molecules
AU2003302134A1 (en) Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
AU2001285219A1 (en) Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
AU2003216184A8 (en) Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof
AU2003250506A8 (en) Method for the characteristation of nucleic acid molecules
EP1660630A4 (en) Nucleic acid biomaterials and methods of formation and use
IL157703A0 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
AU2003303588A1 (en) Methods and compositions for sequencing nucleic acid molecules
AU2002365188A8 (en) Nucleic acid delivery and expression
HUP0303377A3 (en) Method for the detection of nucleic acid molecules
AU2003294652A8 (en) Method and reactor for the amplification of dna
GB2425534B8 (en) Nucleic Acid Complex And Method Of Introducing Nucleic Acid into Cell Using The Same
AU2002367750A8 (en) Isothermal amplification in nucleic acid analysis
IL149679A0 (en) Nucleic acid construct and methods utilizing the same
GB9928674D0 (en) Reagent and method for delivery of molecules into cells
AU2002368251A1 (en) Characterizing nucleic acid and amino acid sequences in silico